Tirzepatide represents a groundbreaking pharmaceutical agent for individuals battling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://lucnsen742187.acidblog.net/71762266/tirzepatide-a-new-frontier-in-diabetes-treatment